Healthy prognosis for local life sciences company

Sep 10, 2010

Antrim-based Fortress Diagnostics is investing £893,000 to expand its operation, with support from Invest Northern Ireland.

The company, which develops, manufactures and distributes a range of medical diagnostic and point of care tests, is aiming to substantially increase its export sales, improve production processes and create an additional 11 jobs.  Invest NI has offered £110,000 of support.

Ian Murphy, Invest NI’s Managing Director of Clients and Entrepreneurship, says: “Life Sciences is a strategically important sector for the Northern Ireland economy and one that Invest NI has identified as a priority. Fortress Diagnostics is among a growing number of highly innovative local companies operating in the sector. The company’s ambitious growth plans reflect its success in the international marketplace, which in turn is ultimately an endorsement of the quality of its products.”

Fortress Diagnostics, based in Antrim Technology Park, currently employs 23 people and exports its products to more than 80 countries worldwide.

Dr Morteza Afrasiabi, Fortress Diagnostics’ Managing Director, says: “This is a significant investment for the company which we hope will enable us to more than double our turnover over the next three years. Invest NI’s assistance will make a crucial contribution, allowing us to invest at a higher level and within a tighter timescale than would otherwise be possible, to ensure we can fully exploit market opportunities.”

Share this Article

Sign up for News

 Enter Code

Latest Features

Leaving the EU: actions to take now to be ready for No Deal
David Roberts, Invest NI Economist
Feb 06, 2019
How can businesses prepare for the data protection implications of a No Deal EU Exit?
David Roberts, Invest NI Economist
Feb 04, 2019
Recruiting workers from the EU – The differences in a Deal and No Deal scenario
David Roberts, Invest NI Economist
Feb 01, 2019
HMRC advice for firms trading with the EU
David Roberts, Invest NI Economist
Dec 06, 2018